Read + Share
Amedeo Smart
Independent Medical Education
Peng Z, Hou X, Huang Y, Xie T, et al. Cost-effectiveness analysis of fruquintinib for metastatic colorectal cancer third-line treatment in China. BMC Cancer 2020;20:990.PMID: 33050905
Email
LinkedIn
Facebook
Twitter
Privacy Policy